Notable companies reporting before tomorrow's open » 20:2510/2610/26/21
TMO, KO, MCD, BMY, BA, GM, FISV, BSX, GD, KHC, HLT, DT, IP, NYCB, HOG, SIX
Notable companies reporting before tomorrow's open, with earnings consensus, include Thermo Fisher (TMO), consensus $4.67... Coca-Cola (KO), consensus 58c... McDonald's (MCD), consensus $2.46... Bristol Myers (BMY), consensus $1.92... Boeing (BA), consensus (21c)... General Motors (GM), consensus 96c... Fiserv (FISV), consensus $1.45... Boston Scientific (BSX), consensus 40c... General Dynamics (GD), consensus $2.98... Kraft Heinz (KHC), consensus 58c... Hilton Worldwide (HLT), consensus 85c... Dynatrace (DT), consensus 16c... International Paper (IP), consensus $1.45... New York Community Bancorp (NYCB), consensus 32c... Harley-Davidson (HOG), consensus 70c... Six Flags (SIX), consensus $1.55.
Pfizer, BioNTech confirm FDA panel supports EUA for COVID vaccine in children » 18:2010/2610/26/21
Pfizer (PFE) and BioNTech…
Pfizer (PFE) and BioNTech (BNTX) announced that the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee voted 17 to 0, with 1 abstention, to recommend the FDA grant Emergency Use Authorization for the companies' COVID-19 vaccine in children 5 to less than12 years of age. VRBPAC is made up of independent experts who advise the FDA on scientific and regulatory matters, including the evaluation of vaccine safety and efficacy. The committee reviewed the totality of scientific evidence shared by the companies, including results from a Phase 2/3 randomized, controlled trial that included ~4,500 children 5 to less than12 years of age. Participants in this age group received a two-dose regimen of 10-microgram doses administered 21 days apart, one-third of the 30-microgram dose used for people 12 years and older. This dose level was carefully selected for use in the trial based on safety, tolerability and immunogenicity data evaluated as part of a dose-ranging study. The Phase 2/3 trial showed a favorable safety profile, robust immune responses and a vaccine efficacy rate of 90.7% in participants without prior SARS-CoV-2 infection, measured from 7 days after the second dose. The Data Monitoring Committee for the study has reviewed the data and has not identified any serious safety concerns related to the vaccine. "We appreciated the opportunity to present our clinical data demonstrating the safety and high efficacy of our COVID-19 vaccine in children 5 to under 12 years of age," said Kathrin U. Jansen, Ph.D., Senior Vice President and Head of Vaccine Research & Development, Pfizer. "COVID-19 is an ongoing threat for the more than 28 million young children in this age group in the U.S., as they remain at risk for this infection. About 10% of all weekly U.S. cases occur in children 5 to under 12 years of age with a potential risk of complications. In addition, immunizing children will help to get us closer to herd immunity, with the potential to stem the pandemic sooner. We thank the FDA advisory committee for their review and positive recommendation in support of Emergency Use Authorization to help protect this young population."
Twitter says it's moving fast to adapt to Apple tracking changes » 18:1710/2610/26/21
Twitter (TWTR) says…
Twitter (TWTR) says moving fast to adapt to Apple (AAPL) tracking changes. Says has "so much more work to do" in terms of machine learning.
Twitter not changing goal of generating $7B+ in annual revenue by 2023 » 18:1110/2610/26/21
Twitter (TWTR) says 12 of…
Twitter (TWTR) says 12 of 14 official Olympics sponsors ran ads on Twitter during 2021 games. Says no change to goal of generating $7B or more in annual revenue by 2023. Says too early to assess overall impact of Apple's (AAPL) App Store changes, but notes "modest" impact in Q3. Comments taken from Q3 earnings conference call.
Trillium shareholders approve acquisition by Pfizer subsidiary » 17:1610/2610/26/21
Trillium Therapeutics (TRIL) announced that its securityholders approved a statutory arrangement with PF Argentum, a wholly-owned, indirect subsidiary of Pfizer (PFE) at the special meeting of Trillium securityholders. Pursuant to the arrangement, PF Argentum will acquire all of the issued and outstanding shares and warrants of Trillium, other than Trillium securities owned by Pfizer and its affiliates. The arrangement is subject to court and regulatory approvals and clearances, as well as other customary closing conditions. Subject to the satisfaction of such conditions, the transaction is expected to be completed in Q4 of 2021 or the first half of 2022.
EVgo, GM open new EV charging station in Colorado » 16:2810/2610/26/21
EVgo (EVGO) announced the…
EVgo (EVGO) announced the opening of a new EV charging station comprised of six new EVgo public direct current fast chargers at Lloyd King Center, located at 6350 Sheridan Boulevard in Arvada, Colorado. "The opening of another EVgo charging station in Colorado builds upon GM (GM) and EVgo's effort to accelerate charging infrastructure build out by adding more than 2,700 DC fast charging stations. Along with all the Ultium-ready chargers at EVgo stations, GM customers can leverage charging capabilities up to 350-kilowatts," said Alex Keros, Lead Architect, EV Infrastructure at General Motors. "We are excited to partner with EVgo to expand charging access here in the Rocky Mountain State and across the country."
FDA panel votes in support of Pfizer-BioNTech vaccine for kids aged 5-11 » 16:1910/2610/26/21
An FDA Advisory Committee…
An FDA Advisory Committee voted 17 yes to 0 no with 1 abstention that the totality of scientific evidence available supports the benefits of the Pfizer (PFE) and BioNTech (BNTX) COVID vaccine when administered as a 2-dose series outweigh its risks for use in children 5-11 years of age.
Apple News expands local news offerings » 16:0310/2610/26/21
Apple announced that…
Apple announced that Apple News will now offer its local news experience in three additional cities in the U.S., namely Charlotte, Miami, and Washington, D.C. "Each experience is curated by Apple News editors and features coverage of topics that are important to local communities, from restaurant openings and real estate trends to big policy decisions. Local news offerings in Apple News provide readers with access to top publications, including Axios Charlotte, the Charlotte Observer, Eater Miami, the Miami Herald, DCist, Washingtonian, the Washington Post, and more," according to the company. Apple News first introduced curated local news experiences for the Bay Area, Houston, Los Angeles, New York, and San Francisco in 2020, and earlier this year, added offerings for Sacramento, San Antonio, and San Diego. Apple News plans to expand its local news feature to additional cities and regions over time. Reference Link
FCA close to plea deal in U.S. emissions fraud investigation, Reuters says » 15:4910/2610/26/21
Fiat Chrysler is close to…
Fiat Chrysler is close to a deal to plead guilty to criminal conduct to settle a multiyear emissions fraud investigation surrounding Ram pickup trucks and Jeep SUVs with diesel engines, Reuters' Mike Spector and David Shepardson report, citing people familiar with the matter. FCA lawyers and DOJ officials are working on a plea deal that could be announced in coming weeks and include financial penalties of $250M-$300M, the authors say. FCA is now part of Stellantis, The Fly notes. Reference Link
GM to resume Chevy Bolt output at Orion plant November 1, Reuters says » 14:0110/2610/26/21
General Motors said it…
General Motors said it plans to resume limited output for two weeks at its Orion factory in Michigan, which has been closed since August and manufactures the Chevrolet Bolt, Reuters' David Shepardson reports. The plant is idled through the end of this month, and the car maker said the limited production will begin November 1 to help optimize battery production and supply chain repair logistics, the author notes. Reference Link